Associations of central and peripheral blood pressure with the renin-angiotensin-aldosterone system in healthy young adults: the African-PREDICT study.


Journal

Hypertension research : official journal of the Japanese Society of Hypertension
ISSN: 1348-4214
Titre abrégé: Hypertens Res
Pays: England
ID NLM: 9307690

Informations de publication

Date de publication:
04 2021
Historique:
received: 07 08 2020
accepted: 17 09 2020
revised: 07 09 2020
pubmed: 31 10 2020
medline: 25 12 2021
entrez: 30 10 2020
Statut: ppublish

Résumé

This study investigated associations of brachial and central blood pressure (BP) with detailed renin-angiotensin-aldosterone system (RAAS) components in a healthy young population stratified according to ethnicity and sex. We included healthy black men (n = 285) and women (n = 304) and white men (n = 278) and women (n = 305) aged 20-30 years old. We derived central systolic BP (cSBP), measured clinic and 24-h systolic and diastolic BP. Aldosterone and equilibrium angiotensin levels were assessed and used for calculating angiotensin-derived markers for plasma renin activity (PRA-S, Angiotensin I + Angiotensin II), angiotensin-converting enzyme (ACE-S, Angiotensin II/Angiotensin I), and two markers for adrenal effects of angiotensin II, the aldosterone-to-renin ratio (ARR-S, Aldosterone/PRA-S) and the aldosterone-to-angiotensin II-ratio (AA2-R, Aldosterone/Angiotensin II)

Identifiants

pubmed: 33122821
doi: 10.1038/s41440-020-00566-1
pii: 10.1038/s41440-020-00566-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-445

Subventions

Organisme : Medical Research Council
ID : MC_PC_16095
Pays : United Kingdom

Références

Rayner BL, Myers JE, Opie LH, Trinder YA, Davidson JS. Screening for primary aldosteronism-normal ranges for aldosterone and renin in three South African population groups. S Afr Med J. 2001;91:594–9.
pubmed: 11544978
Spence JD, Rayner BL. Hypertension in blacks: individualized therapy based on renin/aldosterone phenotyping. Hypertension. 2018;72:263–9.
pubmed: 29941519 doi: 10.1161/HYPERTENSIONAHA.118.11064
Gafane LF, Schutte R, Van Rooyen JM, Schutte AE. Plasma renin and cardiovascular responses to the cold pressor test differ in black and white populations: the SABPA study. J Hum Hypertens. 2016;30:346–51.
pubmed: 26310183 doi: 10.1038/jhh.2015.88
Rayner BL, Owen EP, King JA, Soule SG, Vreede H, Opie LH, et al. A new mutation, R563Q, of the beta subunit of the epithelial sodium channel associated with low-renin, low-aldosterone hypertension. J Hypertens. 2003;21:921–6.
pubmed: 12714866 doi: 10.1097/00004872-200305000-00016
Tu W, Eckert GJ, Hannon TS, Liu H, Pratt LM, Wagner MA, et al. Racial differences in sensitivity of blood pressure to aldosterone. Hypertension. 2014;63:212–8.
doi: 10.1161/HYPERTENSIONAHA.113.02989
Gafane-Matemane LF, Van Rooyen JM, Schutte R, Schutte AE. Aldosterone and renin in relation to surrogate measures of sympathetic activity: the SABPA study. Cardiovasc J Afr. 2019;30:34–40.
pubmed: 30720841 doi: 10.5830/CVJA-2018-065
Scott L, Woodiwiss AJ, Maseko MJ, Veliotes DG, Majane OH, Paiker J, et al. Aldosterone-to-renin ratio and the relationship between urinary salt excretion and blood pressure in a community of African ancestry. Am J Hypertens. 2011;24:951–7.
pubmed: 21451591 doi: 10.1038/ajh.2011.49
Huan Y, DeLoach S, Keith SW, Goodfriend TL, Falkner B. Aldosterone and aldosterone: renin ratio associations with insulin resistance and blood pressure in African Americans. J Am Soc Hypertens. 2012;6:56–65.
pubmed: 22024666 doi: 10.1016/j.jash.2011.09.005
Van Rooyen JM, Poglitsch M, Huisman HW, Gafane-Matemane LF, Breet Y, Malan L. A primary aldosteronism-like phenotype identified with the aldosterone-to-angiotensin II ratio in black men: the SABPA study. Cardiovasc J Afr. 2020;31:130–5.
pubmed: 31781716 pmcid: 8762789
Burrello J, Buffolo F, Domenig O, Tetti M, Pecori A, Monticone S, et al. Renin-angiotensin-aldosterone system triple-A analysis for the screening of primary aldosteronism. Hypertension. 2020;75:163–72.
pubmed: 31760886 doi: 10.1161/HYPERTENSIONAHA.119.13772
Guo Z, Poglitsch M, Cowley D, Domenig O, McWhinney BC, Ungerer JP, et al. Effects of ramipril on the aldosterone/renin ratio and the aldosterone/angiotensin II ratio in patients with primary aldosteronism. Hypertension. 2020;76:488–96.
pubmed: 32507039 doi: 10.1161/HYPERTENSIONAHA.120.14871
He J, Klag MJ, Appel LJ, Charleston J, Whelton PK. The renin-angiotensin system and blood pressure differences between blacks and whites. Am J Hypertens. 1999;12:555–62.
pubmed: 10371364 doi: 10.1016/S0895-7061(99)00030-8
Ahmed AH, Gordon RD, Taylor PJ, Ward G, Pimenta E, Stowasser M. Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men? J Clin Endocrinol Metab. 2011;96:E340–E346.
pubmed: 20962019 doi: 10.1210/jc.2010-1355
Pizzolo F, Raffaelli R, Memmo A, Chiecchi L, Pavan C, Guarini P, et al. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. J Hypertens. 2010;28:135–42.
pubmed: 19952782 doi: 10.1097/HJH.0b013e32833266e3
Banegas JR, Ruilope LM, de la Sierra A, Vinyoles E, Gorostidi M, de la Cruz JJ, et al. Relationship between clinic and ambulatory blood-pressure measurements and mortality. N Eng J Med. 2018;378:509–20.
doi: 10.1056/NEJMoa1712231
Weber T, Wassertheurer S, Schmidt-Trucksäss A, Rodilla E, Ablasser C, Jankowski P, et al. Relationship between 24-hour ambulatory central systolic blood pressure and left ventricular mass: a prospective multicenter study. Hypertension. 2017;70:1157–64.
pubmed: 29061725 doi: 10.1161/HYPERTENSIONAHA.117.09917
McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB. Central blood pressure: current evidence and clinical importance. Eur Heart J. 2014;35:1719–25.
pubmed: 24459197 pmcid: 4155427 doi: 10.1093/eurheartj/eht565
Agabiti-Rosei E, Mancia G, O’Rourke MF, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50:154–60.
pubmed: 17562972 doi: 10.1161/HYPERTENSIONAHA.107.090068
Schneider MP, Delles C, Klingbeil AU, Ludwig M, Kolloch RE, Krekler M, et al. Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial. J Renin Angiotensin Aldosterone Syst. 2008;9:49–56.
pubmed: 18404609 doi: 10.3317/jraas.2008.003
Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213–25.
pubmed: 16476843 doi: 10.1161/CIRCULATIONAHA.105.606962
Schutte AE, Gona PN, Delles C, Uys AS, Burger A, Mels CM, et al. The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension (African-PREDICT): Design, recruitment and initial examination. Eur J Prev Cardiol. 2019;26:458–70.
pubmed: 30681377 pmcid: 6423686 doi: 10.1177/2047487318822354
Patro BK, Jeyashree K, Gupta PK. Kuppuswamy’s socioeconomic status scale 2010—the need for periodic revision. Indian J Pediatr. 2012;79:395–6.
pubmed: 21761123 doi: 10.1007/s12098-011-0517-7
Marfell-Jones T, Stewart A, Olds T. Kinanthropometry IX: Proceedings of the 9th International Conference of the International Society for the Advancement of Kinanthropometry. London and New York: Routledge-Taylor & Francis; 2006.
doi: 10.4324/9780203970157
Hwang M, Yoo J, Kim H, Hwang C, Mackay K, Hemstreet O, et al. Validity and reliability of aortic pulse wave velocity and augmentation index determined by the new cuff-based SphygmoCor Xcel. J Hum Hypertens. 2014;28:475–81.
pubmed: 24430704 doi: 10.1038/jhh.2013.144
Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension. 2001;38:932–7.
pubmed: 11641312 doi: 10.1161/hy1001.096106
Schulz A, Jankowski J, Zidek W, Jankowski V. Absolute quantification of endogenous angiotensin II levels in human plasma using ESI-LC-MS/MS. Clin Proteom. 2014;11:37.
doi: 10.1186/1559-0275-11-37
Olkowicz M, Radulska A, Suraj J, Kij A, Walczak M, Chlopicki S, et al. Development of a sensitive, accurate and robust liquid chromatography/mass spectrometric method for profiling of angiotensin peptides in plasma and its application for atherosclerotic mice. J Chromatogr A. 2015;1393:37–46.
pubmed: 25817477 doi: 10.1016/j.chroma.2015.03.012
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
pubmed: 19414839 pmcid: 2763564 doi: 10.7326/0003-4819-150-9-200905050-00006
Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, et al. Evaluation of the CKD-EPI equation in multiple races and ethnicities. Kidney Int. 2011;79:555–62.
pubmed: 21107446 doi: 10.1038/ki.2010.462
World Health Organization. Protocol for population level sodium determination in 24-h urine samples. WHO/PAHO Regional Expert Group for Cardiovascular Disease Prevention through Population-wide Dietary Salt Reduction: Sub-Group for Research and Surveillance; 2010.
Stolarz-Skrzypek K, Kuznetsova T, Thijs L, Tikhonoff V, Seidlerová J, Richart T, et al. Fatal and nonfatal outcomes, incidence of hypertension, and blood pressure changes in relation to urinary sodium excretion. JAMA. 2011;305:1777–85.
pubmed: 21540421 doi: 10.1001/jama.2011.574
Tomaschitz A, Maerz W, Pilz S, Ritz E, Scharnagl H, Renner W, et al. Aldosterone/renin ratio determines peripheral and central blood pressure values over a broad range. J Am Coll Cardiol. 2010;55:2171–80.
pubmed: 20447545 doi: 10.1016/j.jacc.2010.01.032
Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999;7:355–62.
pubmed: 10440591 doi: 10.1002/j.1550-8528.1999.tb00418.x
Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005;45:356–62.
doi: 10.1161/01.HYP.0000154361.47683.d3 pubmed: 15630041
Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811–20.
pubmed: 28385310 doi: 10.1016/j.jacc.2017.01.052
Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–916.
pubmed: 26934393 doi: 10.1210/jc.2015-4061
Fisher ND, Hurwitz S, Ferri C, Jeunemaitre X, Hollenberg NK, Williams GH. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension. 1999;34:388–94.
pubmed: 10489382 doi: 10.1161/01.HYP.34.3.388
Baker E, Dong Y, Sagnella G, Rothwell M, Onipinla A, Markandu N, et al. Association of hypertension with T594M mutation in β subunit of epithelial sodium channels in black people resident in London. Lancet. 1998;351:1388–92.
pubmed: 9593408 doi: 10.1016/S0140-6736(97)07306-6
London GM, Asmar RG, O’Rourke MF, Safar ME.REASON Project Investigators Mechanism (s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92–99.
pubmed: 14715189 doi: 10.1016/j.jacc.2003.07.039
Rayner BL, Spence JD. Hypertension in blacks: insights from Africa. J Hypertens. 2017;35:234–9.
pubmed: 27841780 doi: 10.1097/HJH.0000000000001171
Daidoh H, Morita H, Mune T, Murayama M, Hanafusa J, Ni H, et al. Responses of plasma adrenocortical steroids to low dose ACTH in normal subjects. Clin Endocrinol (Oxf). 1995;43:311–5.
doi: 10.1111/j.1365-2265.1995.tb02037.x
Poglitsch M, Sturrock E, Danser A. Letter to the editor: Angiotensin quantification by mass spectrometry. Am J Physiol Heart Circ Physiol. 2016;310:H452–H453.
pubmed: 26830339 doi: 10.1152/ajpheart.00933.2015

Auteurs

Lebo F Gafane-Matemane (LF)

Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa. lebo.gafane@nwu.ac.za.
Medical Research Council, Research Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa. lebo.gafane@nwu.ac.za.

Nametsegang L Mokae (NL)

Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Medical Research Council, Research Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.

Yolandi Breet (Y)

Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Medical Research Council, Research Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.

Marko Poglitsch (M)

Attoquant Diagnostics, Vienna, Austria.

Aletta E Schutte (AE)

Hypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Medical Research Council, Research Unit for Hypertension and Cardiovascular Disease, North-West University, Potchefstroom, South Africa.
School of Population Health, University of New South Wales, Sydney, NSW, Australia.
The George Institute for Global Health, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH